SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001140361-22-025746
Filing Date
2022-07-11
Accepted
2022-07-11 17:18:12
Documents
1
Effectiveness Date
2022-07-11

Document Format Files

Seq Description Document Type Size
1 S-8 POS ny20004305x14_s8pos.htm S-8 POS 24305
  Complete submission text file 0001140361-22-025746.txt   25388
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Filer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-254607 | Film No.: 221077671
SIC: 2834 Pharmaceutical Preparations